Efficacy of Shankhapushpi Choorna on Borderline IQ in School Going Children - A Randomized Placebo Controlled Clinical Study
Objective: To study the concepts regarding Medha, Medhya and IQ. Detailed assessment of IQ level of school going children with 6-8 years of age group. To study the efficacy of Shankhapushpi Choorna in the enhancement of IQ of school going children with Borderline IQ. Design: Open randomized placebo controlled clinical study with pre and post-test design. Setting: O.P.D. of Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Udupi and also nearby schools of Udupi. Interventions: A minimum of 40 children under borderline IQ were selected based on the inclusion and exclusion criteria. The selected children were randomly divided into 2 groups of 20 each. Group A (Trial Group) were treated with Shankhapushpi Choorna with dose of 5grams daily at night, after food with lukewarm milk for a duration of 60 days and Group B was administered with Placebo. The follow up period was 30 days after the intervention. Main outcome measures: The subjective criteria were based on the parameters of Grasping power, Memory power, Courage & Activity. The values obtained using Malin’s Intelligence Scale for Indian Children (MISIC) were considered for objective assessment. Results: Over the duration of the study, the trial drug Shankhapushpi Choorna was seen to have a positive effect on all the subjective and objective parameters with statistically highly significant results. Conclusion: Shankhapushpi Choorna with the proper dosage according to the age definitely improves the Medha of children with borderline IQ. The drug can be used as both promotive as well as curative aspects in accordance with intelligence.
Copyright (c) 2020 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.